THOMPSON DAVIS & CO., INC. - SECOND SIGHT MED PRODS INC ownership

SECOND SIGHT MED PRODS INC's ticker is EYESXXXX and the CUSIP is 81362J100. A total of 64 filers reported holding SECOND SIGHT MED PRODS INC in Q4 2015. The put-call ratio across all filers is 0.73 and the average weighting 0.0%.

Quarter-by-quarter ownership
THOMPSON DAVIS & CO., INC. ownership history of SECOND SIGHT MED PRODS INC
ValueSharesWeighting
Q1 2016$1,0000.0%2500.0%0.00%0.0%
Q4 2015$1,000
-97.2%
250
-90.5%
0.00%
-97.6%
Q2 2015$36,0002,6250.04%
Other shareholders
SECOND SIGHT MED PRODS INC shareholders Q4 2015
NameSharesValueWeighting ↓
CARL DOMINO INC 58,435$190,0000.18%
VAN DEN BERG MANAGEMENT I, INC 165,900$584,0000.07%
Granite Investment Partners, LLC 141,206$497,0000.04%
ORACLE INVESTMENT MANAGEMENT INC 50,804$179,0000.03%
JW Asset Management, LLC 8,500$30,0000.02%
Psagot Value Holdings Ltd. 55,362$195,0000.01%
Financial Architects, Inc 5,056$18,0000.01%
B. Riley Wealth Advisors, Inc. 48,226$19,0000.00%
Virtu KCG Holdings LLC 43,205$152,0000.00%
Edge Wealth Management LLC 2,000$7,0000.00%
View complete list of SECOND SIGHT MED PRODS INC shareholders